Financial Architects Inc reduced its stake in Express Scripts Holding Co (NASDAQ:ESRX) by 69.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,957 shares of the company’s stock after selling 4,370 shares during the period. Financial Architects Inc’s holdings in Express Scripts were worth $186,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. BlackRock Inc. lifted its holdings in shares of Express Scripts by 1.5% during the second quarter. BlackRock Inc. now owns 35,424,185 shares of the company’s stock valued at $2,735,103,000 after purchasing an additional 538,578 shares in the last quarter. Northern Trust Corp lifted its holdings in shares of Express Scripts by 0.4% during the second quarter. Northern Trust Corp now owns 10,205,190 shares of the company’s stock valued at $787,943,000 after purchasing an additional 40,656 shares in the last quarter. Abrams Capital Management L.P. bought a new position in shares of Express Scripts during the second quarter valued at $204,846,000. American Century Companies Inc. lifted its holdings in shares of Express Scripts by 18.9% during the second quarter. American Century Companies Inc. now owns 2,492,801 shares of the company’s stock valued at $192,469,000 after purchasing an additional 395,723 shares in the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. lifted its holdings in shares of Express Scripts by 6.3% during the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 2,024,126 shares of the company’s stock valued at $156,283,000 after purchasing an additional 120,214 shares in the last quarter. 84.74% of the stock is currently owned by hedge funds and other institutional investors.
ESRX stock opened at $94.87 on Tuesday. Express Scripts Holding Co has a fifty-two week low of $59.17 and a fifty-two week high of $97.22. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.59 and a current ratio of 0.71. The stock has a market capitalization of $53.00 billion, a price-to-earnings ratio of 13.36, a PEG ratio of 1.19 and a beta of 1.01.
In other Express Scripts news, insider Christine Houston sold 12,898 shares of the stock in a transaction dated Friday, August 10th. The stock was sold at an average price of $85.00, for a total value of $1,096,330.00. Following the transaction, the insider now owns 110,908 shares of the company’s stock, valued at $9,427,180. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.79% of the stock is currently owned by corporate insiders.
A number of brokerages have recently issued reports on ESRX. BidaskClub raised Express Scripts from a “buy” rating to a “strong-buy” rating in a report on Friday, October 12th. Credit Suisse Group downgraded Express Scripts from an “outperform” rating to a “neutral” rating and upped their price target for the company from $90.00 to $96.50 in a report on Tuesday, September 18th. ValuEngine raised Express Scripts from a “hold” rating to a “buy” rating in a report on Monday, September 17th. Royal Bank of Canada upped their price target on Express Scripts to $94.00 and gave the company an “outperform” rating in a report on Monday, August 27th. Finally, William Blair raised Express Scripts from a “market perform” rating to an “outperform” rating in a report on Wednesday, August 1st. Two investment analysts have rated the stock with a sell rating, twelve have issued a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. Express Scripts currently has a consensus rating of “Hold” and a consensus price target of $86.36.
Express Scripts Company Profile
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
Featured Article: Trading Strategy
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.